PAHC Phibro Animal Health Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 18
Relative Valuation: Rel. Valuation: 95
Relative Profitability: Rel. Profitability: 80

EPS in 2026 (TTM): $2.34

Last Report Period Date: Mar 31, 2026

As of June 2026, PAHC's current EPS stands at $2.34, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $1.19, which marks an increase compared to its EPS of $0.06 in 2024. PAHC reported an EPS of $0.59 for the quarterly report ending on Mar 31, 2026.

PAHC earnings history

Historical annual and quarterly earnings per share (EPS) data for Phibro Animal Health
EPS (TTM)
$2.34
EPS Growth YoY (Quarterly)
13.5%
EPS (Quarterly)
$0.59
EPS Growth (Quarterly)
-13.2%

For 2025, Phibro Animal Health's EPS was $1.19, an increase of 1,883.3% from $0.06 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $0.59, showing a 13.5% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $2.34. For the year 2024, the yearly earnings per share was $0.06, marking a decrease of 92.6% from 2023.

PAHC earnings chart

PAHC EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
13.5%
EPS growth YoY
1,883.3%
EPS growth 3Y avg
-0.6%
EPS growth 5Y avg
7.5%

During the last 12 months, Phibro Animal Health has seen an EPS growth of 13.5% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -0.6% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 7.5%. A 10-year view shows that PAHC has seen an average EPS growth of -2.6% per year.

PAHC Earnings Waterfall

Breakdown of revenue, profit and net income for Phibro Animal Health

PAHC Earnings vs Peers

What are the earnings of PAHC compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
ZTS Zoetis Inc 12.72 10.2% 10.2% 11.9%
PAHC Phibro Animal Health Corp 13.05 1,883.3% -0.6% 7.5%
MRK Merck & Co Inc 33.5 8% 8.4% 21.2%
ADM Archer-Daniels-Midland Co 34.01 -39.1% -33.9% -6.7%
LLY ELI LILLY & Co 39.27 95.6% 49.2% 27.5%
ICCC Immucell Corp N/A 53.8% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.